- Home
- NAT vs IMTX Comparison
NAT vs IMTX Comparison
Compare NAT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAT
- IMTX
- Stock Information
- Founded
- NAT 1995
- IMTX N/A
- Country
- NAT Bermuda
- IMTX Germany
- Employees
- NAT N/A
- IMTX N/A
- Industry
- NAT Marine Transportation
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NAT Consumer Discretionary
- IMTX Health Care
- Exchange
- NAT Nasdaq
- IMTX Nasdaq
- Market Cap
- NAT 603.5M
- IMTX 653.9M
- IPO Year
- NAT 1997
- IMTX N/A
- Fundamental
- Price
- NAT $3.18
- IMTX $5.34
- Analyst Decision
- NAT Hold
- IMTX Strong Buy
- Analyst Count
- NAT 2
- IMTX 4
- Target Price
- NAT $3.50
- IMTX $14.67
- AVG Volume (30 Days)
- NAT 1.8M
- IMTX 771.6K
- Earning Date
- NAT 08-28-2025
- IMTX 08-13-2025
- Dividend Yield
- NAT 10.91%
- IMTX N/A
- EPS Growth
- NAT N/A
- IMTX N/A
- EPS
- NAT 0.06
- IMTX N/A
- Revenue
- NAT $301,169,000.00
- IMTX $152,823,253.00
- Revenue This Year
- NAT N/A
- IMTX N/A
- Revenue Next Year
- NAT $6.07
- IMTX N/A
- P/E Ratio
- NAT $50.92
- IMTX N/A
- Revenue Growth
- NAT N/A
- IMTX 83.61
- 52 Week Low
- NAT $2.13
- IMTX $3.30
- 52 Week High
- NAT $3.83
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- NAT 68.86
- IMTX 40.26
- Support Level
- NAT $2.96
- IMTX $5.16
- Resistance Level
- NAT $3.07
- IMTX $5.56
- Average True Range (ATR)
- NAT 0.08
- IMTX 0.39
- MACD
- NAT 0.02
- IMTX -0.09
- Stochastic Oscillator
- NAT 93.59
- IMTX 20.00
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.